National Institutes of Health
https://www.nih.gov/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From National Institutes of Health
Biosimilars And Beyond: Celltrion Aiming For $9bn Post Merger
After years of talks, Korea's Celltrion Group is finally moving ahead with the merger of three key affiliates aimed at improving cost competitiveness and securing investment resources, as well as simplifying transaction structures and improving governance.
Biosimilars And Beyond: Celltrion Aiming For $9bn Post Merger
After years of talks, Korea's Celltrion Group is finally moving ahead with the merger of three key affiliates aimed at improving cost competitiveness and securing investment resources, as well as simplifying transaction structures and improving governance.
Iksuda Aims For Best-In-Class Cancer ADCs With Toolbox Approach To Technology
Emerging Company Profile: While the UK biotech boasts a promising in-house platform technology, it believes a less restrictive approach to R&D could help it develop superior antibody-drug conjugates for cancer.
Next Potential Big ADC Player? Korean Firms Take It Up A Notch
Scrip takes a look at the increasingly competitive landscape of Korean antibody-drug conjugate developers, which are now vying to catch up with their global rivals in the hot area.
Company Information
- Industry
- Academic and Research Institutions
- Other Names / Subsidiaries
-
- The National Institutes of Health (NIH)
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice